GENERAL ATLANTIC, L.P.

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    16

  • Value ($000)

    $2,809,302

  • Date Filed
    02/07/2025
  • Form type
    13F-HR
  • CIK
    0001017645
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

DLOCAL

CL A
G29018101
$719.59M
26 %

63,906,695

ALHC
ALHC

ALIGNMENT HEALTHCARE

COM
01625V104
$686.17M
24 %

60,993,323

ALKT
ALKT

ALKAMI

COM
01644J108
$353.79M
13 %

9,645,318

---

XP, INC

CL A
G98239109
$350.97M
13 %

29,617,733

CNTA
CNTA

CENTESSA PHARMACEUTICALS

ADS
152309100
$162.17M
6 %

9,681,818

AKRO
AKRO

AKERO THERAPEUTICS

COM
00973Y108
$145.61M
5 %

5,233,989

---

PHARVARIS

COM
N69605108
$144.37M
5 %

7,531,252

EWCZ
EWCZ

EUROPEAN WAX CENTER

CL A
29882P106
$87.45M
3 %

13,110,492

---

ROYALTY PHARMA

CL A
G7709Q104
$38.27M
1 %

1,500,000

IMCR
IMCR

IMMUNOCORE

ADS
45258D105
$37.22M
1 %

1,261,684

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 16